Change of maternal pertussis vaccine, January 2020

The maternal pertussis immunisation programme commenced in October 2012, initially using Repevax® vaccine (dTaP/IPV). From July 2014, Boostrix®-IPV (dTaP/IPV) has been supplied.

From mid-January 2020, Repevax® will be available to order through ImmForm for use in the maternal pertussis immunisation programme instead of Boostrix®- IPV. This is a temporary change and it is anticipated that supplies will revert back to Boostrix®-IPV in autumn 2020. This change is necessary as PHE is running down all stock of Repevax® before the introduction of Boostrix-IPV across both the maternal pertussis and the pre-school booster programmes.

There is no other change to the maternal pertussis immunisation programme, further details about this programme can be found in chapter 24 of the Green Book

Infection and infectious diseasesNewsObstetrics and gynaecologyVaccination